What dosage does Mounjaro go up to, and how does the titration work?

The six doses and what each step is actually for

The 2.5 mg pen is the first four weeks. Its job is adjustment, giving your gut time to adapt to tirzepatide's dual GIP and GLP-1 action before any real therapeutic work begins. Expect very little appetite change at this level; that is expected, not a sign that the medicine isn't working. After four weeks, a prescriber assessing good tolerability will typically move you to 5 mg. From there the staircase continues: 7.5 mg, 10 mg, 12.5 mg, and then the maximum, 15 mg. Each rung requires roughly a month before the next is considered. If you are wondering what doses Mounjaro comes in and how each one is used, that page sets out the full picture clearly. If you want a clear map of how the full Mounjaro dose schedule unfolds week by week, that page walks through the timeline in detail.

Not everyone reaches 15 mg, and that is fine. The goal is the lowest dose that produces meaningful progress with manageable side effects, some people do very well at 7.5 mg or 10 mg and stay there. The NICE appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if less than 5% weight loss occurs after six months at the highest tolerated dose, which underlines why reaching the maximum isn't always the objective.

The NHS's tirzepatide medicines page gives a plain-English overview of how the doses and titration work for patients, including what to do if you miss a dose or experience side effects.

What the ceiling dose actually does in practice

At 15 mg, the clinical trial evidence is at its strongest. In SURMOUNT-1 (which enrolled 2,539 adults with obesity but without diabetes) the 15 mg group saw an average body-weight reduction of around 20 to 21% over 72 weeks. To put that in everyday terms, someone starting at 100 kg might expect to lose roughly 20 kg on average, though individual results vary considerably. The evidence behind the 15 mg ceiling and what the trial data says about it is worth reading if you want the deeper picture.

The medicine slows gastric emptying and reduces appetite through two hormonal pathways simultaneously, which is why tirzepatide's ceiling-dose outcomes in head-to-head evidence outperformed semaglutide 2.4 mg in the SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025. That said, biology is individual. The best dose is the one your prescriber determines works for you, not the highest one available.

Side effects are most common when starting or stepping up: nausea, loose stools, indigestion and fatigue are the most frequently reported, and they tend to ease within a week or two of settling at a new dose. If they don't, that is a conversation for your prescriber rather than a reason to push through.

Who decides when you move up, and why that matters

This is the part that trips people up most often. The titration schedule on the leaflet is a framework; it is not a guarantee of progression. A prescriber considers your weight trend, your side-effect experience, your current health picture and any relevant blood results before recommending a step up. Moving too fast tends to mean worse nausea and a higher chance of stopping early. Moving too slowly means missing out on therapeutic benefit unnecessarily.

At a regulated online pharmacy, every dose increase requires a fresh clinical review, not just a click. Our prescribers at our clinical team review each request on the same day, personally. That review is where the decision gets made, not by an algorithm, and not by the patient alone. If you are thinking about whether a particular dose might suit you, understanding where tirzepatide treatment typically begins and what the prescriber looks for is useful background.

One practical note: if your review happens to fall near a bank holiday or you're ordering around payday at the end of the month when demand is higher, build in a day or two of buffer so the timing of your next pen isn't disrupted.

What the cost picture looks like across the dose range

The price of Mounjaro in the UK changes as the dose increases, since higher-strength pens carry a different list price. Since Eli Lilly revised its UK pricing in September 2025, the spread between the 2.5 mg and 15 mg pens has become more pronounced, something worth factoring into a longer-term budget. It is also worth familiarising yourself with how Mounjaro dosage works in ml, particularly if you are comparing pens or checking that you are administering the correct volume. If you are exploring the financial side, the cost context for Mounjaro in the UK covers what different doses and providers typically charge, and what a transparent private price should include.

At nume, one price covers the consultation, the prescription, the medicine and free next-working-day delivery, no separate fees at each step, no surprises when you move to the next dose. What you'll find on the treatment page is the current pricing by dose, set out plainly.

These are prescription-only medicines. How far up the dose ladder you go is a clinical decision, not a commercial one, and it rests with your prescriber at every stage.